0001415889-23-005764.txt : 20230403
0001415889-23-005764.hdr.sgml : 20230403
20230403161140
ACCESSION NUMBER: 0001415889-23-005764
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230401
FILED AS OF DATE: 20230403
DATE AS OF CHANGE: 20230403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brennan Kevin M.
CENTRAL INDEX KEY: 0001971303
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 23792733
MAIL ADDRESS:
STREET 1: C/O XILIO THERAPEUTICS, INC.
STREET 2: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-04032023_080434.xml
X0407
4
2023-04-01
0001840233
Xilio Therapeutics, Inc.
XLO
0001971303
Brennan Kevin M.
828 WINTER STREET
SUITE 300
WALTHAM
MA
02451
false
true
false
false
SVP, FINANCE AND ACCOUNTING
0
Stock Option (right to buy)
3.17
2023-04-01
4
A
0
55000
0
A
2033-03-31
Common Stock
55000
55000
D
The option was granted on April 1, 2023 and shall vest on March 30, 2024 with respect to 25% of the shares of common stock underlying the stock option, and the remaining 75% of the shares of common stock underlying the stock option shall continue to vest in 36 equal monthly installments thereafter until March 30, 2027.
/s/ Julia Walcott, Attorney-in-Fact
2023-04-03